Schedule 13G ownership disclosure

RXI PHARMACEUTICALS CORP

Security class unavailable · CUSIP: 74979C303

Event date: 2015-05-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,750,000
Percent of class
4.2400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-15-000060
Form type
SC 13G
Filer
Phio Pharmaceuticals Corp.
CIK
CIK 1533040
Filed
Jun 05, 2015
Reporting period
May 28, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub